TfR2ヘテロ接合型変異で発症したヘモクロマトーシスの1例
症例は38歳,男性.肝機能障害にて当科を受診し,血液検査で肝酵素の上昇に加え,血清鉄,フェリチンの上昇を認めた.肝生検組織の鉄染色で肝細胞に鉄沈着を認めた.輸血や鉄剤での治療の既往はなく,HFE,HJV,HAMP,TfR2,SLC40A1の鉄代謝関連遺伝子検査を行い,TfR2のヘテロ接合型変異(c.1206c>M)を認めた.以上の結果からtype3遺伝性ヘモクロマトーシスと診断し,食生活の変更とともに定期的な瀉血療法を行ったところ,血清フェリチンは正常化し,肝機能は改善した.TfR2の変異による遺伝性ヘモクロマトーシスは常染色体劣性遺伝であり,通常はホモ接合型で発症する.本症例はTfR2のヘテ...
Saved in:
Published in | 肝臓 Vol. 63; no. 3; pp. 151 - 157 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
一般社団法人 日本肝臓学会
01.03.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 0451-4203 1881-3593 |
DOI | 10.2957/kanzo.63.151 |
Cover
Abstract | 症例は38歳,男性.肝機能障害にて当科を受診し,血液検査で肝酵素の上昇に加え,血清鉄,フェリチンの上昇を認めた.肝生検組織の鉄染色で肝細胞に鉄沈着を認めた.輸血や鉄剤での治療の既往はなく,HFE,HJV,HAMP,TfR2,SLC40A1の鉄代謝関連遺伝子検査を行い,TfR2のヘテロ接合型変異(c.1206c>M)を認めた.以上の結果からtype3遺伝性ヘモクロマトーシスと診断し,食生活の変更とともに定期的な瀉血療法を行ったところ,血清フェリチンは正常化し,肝機能は改善した.TfR2の変異による遺伝性ヘモクロマトーシスは常染色体劣性遺伝であり,通常はホモ接合型で発症する.本症例はTfR2のヘテロ接合型変異であったが,肉類の摂取量が多く,生活習慣が発症に寄与した可能性が示唆され,瀉血療法に加えて生活習慣の変更が鉄過剰の改善に有効であった. |
---|---|
AbstractList | 症例は38歳,男性.肝機能障害にて当科を受診し,血液検査で肝酵素の上昇に加え,血清鉄,フェリチンの上昇を認めた.肝生検組織の鉄染色で肝細胞に鉄沈着を認めた.輸血や鉄剤での治療の既往はなく,HFE,HJV,HAMP,TfR2,SLC40A1の鉄代謝関連遺伝子検査を行い,TfR2のヘテロ接合型変異(c.1206c>M)を認めた.以上の結果からtype3遺伝性ヘモクロマトーシスと診断し,食生活の変更とともに定期的な瀉血療法を行ったところ,血清フェリチンは正常化し,肝機能は改善した.TfR2の変異による遺伝性ヘモクロマトーシスは常染色体劣性遺伝であり,通常はホモ接合型で発症する.本症例はTfR2のヘテロ接合型変異であったが,肉類の摂取量が多く,生活習慣が発症に寄与した可能性が示唆され,瀉血療法に加えて生活習慣の変更が鉄過剰の改善に有効であった. |
Author | 森野, 加帆里 阿部, 慎太郎 生田, 克哉 原田, 大 宮川恒, 一郎 土岐, 康通 柴田, 道彦 西尾, 仁 熊元, 啓一郎 大江, 晋司 巽, 康彰 本間, 雄一 林, 久男 |
Author_xml | – sequence: 1 fullname: 原田, 大 organization: 産業医科大学第3内科学 – sequence: 1 fullname: 森野, 加帆里 organization: 産業医科大学第3内科学 – sequence: 1 fullname: 巽, 康彰 organization: 愛知学院大学薬物治療学 – sequence: 1 fullname: 林, 久男 organization: 愛知学院大学薬物治療学 – sequence: 1 fullname: 柴田, 道彦 organization: 産業医科大学第3内科学 – sequence: 1 fullname: 熊元, 啓一郎 organization: 産業医科大学第2病理学 – sequence: 1 fullname: 生田, 克哉 organization: 北海道赤十字血液センター – sequence: 1 fullname: 宮川恒, 一郎 organization: 産業医科大学第3内科学 – sequence: 1 fullname: 土岐, 康通 organization: 旭川医科大学消化器・血液腫瘍制御内科学 – sequence: 1 fullname: 阿部, 慎太郎 organization: 産業医科大学第3内科学 – sequence: 1 fullname: 本間, 雄一 organization: 産業医科大学第3内科学 – sequence: 1 fullname: 大江, 晋司 organization: 産業医科大学第3内科学 – sequence: 1 fullname: 西尾, 仁 organization: 産業医科大学第3内科学 |
BookMark | eNo9kMtKw0AYhQepYKzd-Rqp_8wkk5mVSPEGFUHqOkwmGW2trSTd6C4NaKUgbqS6qSCKKy87UcSXGWNfw1rFzTmL83EW3ywqtNqtCKF5DGUiXG9hT7aO2mVGy9jFU8jCnGObuoIWkAWOi22HAJ1BpSSpBwCEeSAEsdBGTW8Rk12a7NhkD19nd_l5Lx_289vT0cWzSe9HV2-jwYlJBya9nmA3pvs0Jk02NFnPZO-m-2K6ryZ9xJ8f_Tk0rWUziUp_XUTbK8u1yppd3VxdryxV7QbxCNhU61CEgVYQCiWJJCxQhOiQOFRRrLEHVLuYK-I5UQhKcCaAg3Q5hZAx4LSIFn9_G0lH7kT-QVzfl_GhL-NOXTUjf-LCZ9SnPzEW8r-oXRn7DUm_ASidc_Y |
ContentType | Journal Article |
Copyright | 2022 一般社団法人 日本肝臓学会 |
Copyright_xml | – notice: 2022 一般社団法人 日本肝臓学会 |
DOI | 10.2957/kanzo.63.151 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1881-3593 |
EndPage | 157 |
ExternalDocumentID | article_kanzo_63_3_63_151_article_char_ja |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS CS3 JSF KQ8 OK1 P2P RJT |
ID | FETCH-LOGICAL-j2720-3ffd9dbfc0d9ca2a26bc22fd243c31f1703f518c274ed0c9869080a5830d66083 |
ISSN | 0451-4203 |
IngestDate | Wed Sep 03 06:30:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j2720-3ffd9dbfc0d9ca2a26bc22fd243c31f1703f518c274ed0c9869080a5830d66083 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/kanzo/63/3/63_151/_article/-char/ja |
PageCount | 7 |
ParticipantIDs | jstage_primary_article_kanzo_63_3_63_151_article_char_ja |
PublicationCentury | 2000 |
PublicationDate | 20220300 |
PublicationDateYYYYMMDD | 2022-03-01 |
PublicationDate_xml | – month: 03 year: 2022 text: 20220300 |
PublicationDecade | 2020 |
PublicationTitle | 肝臓 |
PublicationTitleAlternate | 肝臓 |
PublicationYear | 2022 |
Publisher | 一般社団法人 日本肝臓学会 |
Publisher_xml | – name: 一般社団法人 日本肝臓学会 |
References | 21) Hino K, Nishina S, Hara Y. Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis. J Gastroenterol Hepatol 2013; 28 Suppl 4: 93-98 1) Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet 2016; 388: 706-716 5) Hayashi H, Wakusawa S, Motonishi S, et al. Genetic background of primary iron overload syndromes in Japan. Intern Med 2006; 45: 1107-1111 16) Koyama C, Wakusawa S, Hayashi H, et al. Two novel mutations, L490R and V561X, in the transferrin receptor 2 in Japanese patients with hemochromatosis. Haematologica 2005; 90: 302-307 18) Majore S, Ricerca BM, Radio FC, et al. Type 3 hereditary hemochromatosis in a patient from sub-Saharan Africa: is there a link between African iron overload and TFR2 dysfunction? Blood Cells Mol Dis 2013; 50: 31-32 12) De Domenico I, Ward DM, Musci G, et al. Iron overload due to mutations in ferroportin. Haematologica 2006; 91: 92-95 15) Hattori A, Wakusawa S, Hayashi H, et al. AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. Hepatol Res 2003; 26: 154-156 19) Fujihara J, Yasuda T, Kimura-Kataoka K, et al. Association of SNPs in transferrin and transferrin receptor genes with blood iron levels in human. Leg Med (Tokyo) 2019; 36: 17-20 11) Hollerer I, Bachmann A, Muckenthaler MU. Pathophysiological consequences and benefits of HFE mutations: 20 years of research. Haematologica 2017; 102: 809-817 6) Hayashi H, Yano M, Urawa N, et al. A 10-year follow-up study of a Japanese family with ferroportin disease A: mild iron overload with mild hyperferritinemia co-occurring with hyperhepcidinemia may be benign. Intern Med 2018; 57: 2865-2871 13) Bardou-Jacquet E, Ben Ali Z, Beaumont-Epinette MP, et al. Non-HFE hemochromatosis: pathophysiological and diagnostic aspects. Clin Res Hepatol Gastroenterol 2014; 38: 143-154 20) Pichler I, Minelli C, Sanna S, et al. Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum Mol Genet 2011; 20: 1232-1240 3) Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010; 139: 393-408 10) Barton JC, Edwards CQ, Acton RT. HFE gene: Structure, function, mutations, and associated iron abnormalities. Gene 2015; 574: 179-192 4) Bomford A. Genetics of haemochromatosis. Lancet 2002; 360: 1673-1681 14) 土田健一, 種田紳二, 三澤和史, 他. 糖尿病, 下垂体性腺機能低下症, 肝線維化を呈した新規TfR2遺伝子変異による原発性ヘモクロマトーシス (HH Type3) の1例. 糖尿病 2010; 53: 247-252 7) Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999; 274: 20826-20832 2) Ikuta K, Hatayama M, Addo L, et al. Iron overload patients with unknown etiology from national survey in Japan. Int J Hematol 2017; 105: 353-360 9) Girelli D, Trombini P, Busti F, et al. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica 2011; 96: 500-506 17) Kawaguchi T, Ikuta K, Tatsumi Y, et al. Identification of heterozygous p.T150C and p.V274M mutations in HJV gene in a Japanese patient with mild phenotype of juvenile hemochromatosis: A case report. Hepatol Res 2019; 50: 144-150 8) Radio FC, Majore S, Binni F, et al. TFR2-related hereditary hemochromatosis as a frequent cause of primary iron overload in patients from Central-Southern Italy. Blood Cells Mol Dis 2014; 52: 83-87 |
References_xml | – reference: 12) De Domenico I, Ward DM, Musci G, et al. Iron overload due to mutations in ferroportin. Haematologica 2006; 91: 92-95 – reference: 14) 土田健一, 種田紳二, 三澤和史, 他. 糖尿病, 下垂体性腺機能低下症, 肝線維化を呈した新規TfR2遺伝子変異による原発性ヘモクロマトーシス (HH Type3) の1例. 糖尿病 2010; 53: 247-252 – reference: 21) Hino K, Nishina S, Hara Y. Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis. J Gastroenterol Hepatol 2013; 28 Suppl 4: 93-98 – reference: 17) Kawaguchi T, Ikuta K, Tatsumi Y, et al. Identification of heterozygous p.T150C and p.V274M mutations in HJV gene in a Japanese patient with mild phenotype of juvenile hemochromatosis: A case report. Hepatol Res 2019; 50: 144-150 – reference: 5) Hayashi H, Wakusawa S, Motonishi S, et al. Genetic background of primary iron overload syndromes in Japan. Intern Med 2006; 45: 1107-1111 – reference: 11) Hollerer I, Bachmann A, Muckenthaler MU. Pathophysiological consequences and benefits of HFE mutations: 20 years of research. Haematologica 2017; 102: 809-817 – reference: 19) Fujihara J, Yasuda T, Kimura-Kataoka K, et al. Association of SNPs in transferrin and transferrin receptor genes with blood iron levels in human. Leg Med (Tokyo) 2019; 36: 17-20 – reference: 20) Pichler I, Minelli C, Sanna S, et al. Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum Mol Genet 2011; 20: 1232-1240 – reference: 4) Bomford A. Genetics of haemochromatosis. Lancet 2002; 360: 1673-1681 – reference: 6) Hayashi H, Yano M, Urawa N, et al. A 10-year follow-up study of a Japanese family with ferroportin disease A: mild iron overload with mild hyperferritinemia co-occurring with hyperhepcidinemia may be benign. Intern Med 2018; 57: 2865-2871 – reference: 10) Barton JC, Edwards CQ, Acton RT. HFE gene: Structure, function, mutations, and associated iron abnormalities. Gene 2015; 574: 179-192 – reference: 18) Majore S, Ricerca BM, Radio FC, et al. Type 3 hereditary hemochromatosis in a patient from sub-Saharan Africa: is there a link between African iron overload and TFR2 dysfunction? Blood Cells Mol Dis 2013; 50: 31-32 – reference: 13) Bardou-Jacquet E, Ben Ali Z, Beaumont-Epinette MP, et al. Non-HFE hemochromatosis: pathophysiological and diagnostic aspects. Clin Res Hepatol Gastroenterol 2014; 38: 143-154 – reference: 15) Hattori A, Wakusawa S, Hayashi H, et al. AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. Hepatol Res 2003; 26: 154-156 – reference: 1) Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet 2016; 388: 706-716 – reference: 9) Girelli D, Trombini P, Busti F, et al. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica 2011; 96: 500-506 – reference: 7) Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999; 274: 20826-20832 – reference: 8) Radio FC, Majore S, Binni F, et al. TFR2-related hereditary hemochromatosis as a frequent cause of primary iron overload in patients from Central-Southern Italy. Blood Cells Mol Dis 2014; 52: 83-87 – reference: 2) Ikuta K, Hatayama M, Addo L, et al. Iron overload patients with unknown etiology from national survey in Japan. Int J Hematol 2017; 105: 353-360 – reference: 3) Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010; 139: 393-408 – reference: 16) Koyama C, Wakusawa S, Hayashi H, et al. Two novel mutations, L490R and V561X, in the transferrin receptor 2 in Japanese patients with hemochromatosis. Haematologica 2005; 90: 302-307 |
SSID | ssib002670992 ssib000940394 ssib002670224 ssib058493441 ssj0069113 ssib005879686 ssib002484534 |
Score | 2.2944317 |
Snippet | ... |
SourceID | jstage |
SourceType | Publisher |
StartPage | 151 |
SubjectTerms | TfR2 ヘテロ接合型変異 ヘモクロマトーシス 生活習慣 遺伝性 |
Title | TfR2ヘテロ接合型変異で発症したヘモクロマトーシスの1例 |
URI | https://www.jstage.jst.go.jp/article/kanzo/63/3/63_151/_article/-char/ja |
Volume | 63 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 肝臓, 2022/03/01, Vol.63(3), pp.151-157 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9VAMNQK4kX8xG96cI-vJtmP7B4376UUpYLSQm8hn-AT2iLtxdt7D7RSEC9SvVQQxZMfN1HEH-DfiM_-DWc2m9e09FB7CZPNzO58JJmZzezGcW6JUnG3EJCpcuV2WO6n8B4ssg4VZVL6PCmZh2uHF-6J-SV2Z5kvT5343apa2lhPZ7Mnh64rOY5VoQ3siqtk_8Oyk06hAWCwLxzBwnA8mo3LBz6JKJGUKGkBKSygeyQSREZEcxJxolwipQEiIkMENISRikQBUZyErqHyiA5MiyKhNkBAZGAvqQkwd3BQXbPhEz3XGr3GiRrGGuSwa5HDoAFUM3rkkYiREFlsh80kkoinegYAtiZvKxQEZESWoJmhIHDTWPF0sIcmiAaugBmFHcioQZOaaBeBUBrd1Ze77f6Bz7DX4INekG-OTaHb7h8kxf2GEY2hSJI3PAXtuRVIyyfFZeZpMOgSS05QOEl0F-m0UQPaK0TOof-QoqUQWRvrUCRBKoHjopUB6Bryg9oy-ugRLQx5lyjdcgCMQ37vu7VKi9pBSel1KLdqth7MuoiH7QkO4448u5lvYc-Cw5ymr8yfnh9BLrI6K-jshGjfNuT2Jo8NWixoTPEAuHFzBZcJxn3IVU76QWBKJu7eb4X6irm0PZXAJOO0PRUQYDi571y1vvhzGSixt9UhxM2KmlC-jroEOG1TTdLorF7kgrLdbksGgWYf0q6mZNNEkYtnnTM2_ZvRtTDnnKl-ct45tWALXC44C_hIV6PX1ehpNfr098WH8cvN8c7W-P3z3Vdfq8HH3Tc_drefVYPtavDWoL2rhl8AsxrtVKPNavSzGn6rht-rwWfvz6-ti87SXLTYne_YP550-lgP0aFlmas8LTM3V1niJ75IM98vc5_RjHqlB-655J7M_IAVuZsp_J2cdBMuqZsLAdnUJWd6ZXWluOzM8DyTXkFpmijGcsZTiPWTArqGDIgnXF1xZK2IeK3e1iY-soWvHp_0mnN67zm77kyvP94obkBUv57eNLfLPxRgxtQ |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TfR2%E3%83%98%E3%83%86%E3%83%AD%E6%8E%A5%E5%90%88%E5%9E%8B%E5%A4%89%E7%95%B0%E3%81%A7%E7%99%BA%E7%97%87%E3%81%97%E3%81%9F%E3%83%98%E3%83%A2%E3%82%AF%E3%83%AD%E3%83%9E%E3%83%88%E3%83%BC%E3%82%B7%E3%82%B9%E3%81%AE1%E4%BE%8B&rft.jtitle=%E8%82%9D%E8%87%93&rft.au=%E5%8E%9F%E7%94%B0%2C+%E5%A4%A7&rft.au=%E6%A3%AE%E9%87%8E%2C+%E5%8A%A0%E5%B8%86%E9%87%8C&rft.au=%E5%B7%BD%2C+%E5%BA%B7%E5%BD%B0&rft.au=%E6%9E%97%2C+%E4%B9%85%E7%94%B7&rft.date=2022-03-01&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E3%80%80%E6%97%A5%E6%9C%AC%E8%82%9D%E8%87%93%E5%AD%A6%E4%BC%9A&rft.issn=0451-4203&rft.eissn=1881-3593&rft.volume=63&rft.issue=3&rft.spage=151&rft.epage=157&rft_id=info:doi/10.2957%2Fkanzo.63.151&rft.externalDocID=article_kanzo_63_3_63_151_article_char_ja |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0451-4203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0451-4203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0451-4203&client=summon |